Physician profile
Aaronpaul Singh
NPI 1689012858
$973.35
in general payments reported to CMS, 2019-2025
10 companies · $55.54 in 2025
The $55.54 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $131 · 2021: $596 · 2022: $78.83 · 2023: $15.20 · 2024: $96.90 · 2025: $55.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $167.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $457.74 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $140.72 | 2021 | |
| Novo Nordisk INC | $123.47 | 2021-2024 | Ozempic, Rybelsus |
| Pfizer INC. | $65.87 | 2020-2025 | |
| Nobel Biocare USA | $60.93 | 2021 | |
| Glaxosmithkline, LLC. | $41.47 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Kowa Pharmaceuticals America, INC. | $31.68 | 2022 | |
| Merck Sharp & Dohme LLC | $20.00 | 2024 | Gardasil 9, Gardasil, Capvaxive |
| Nestle Healthcare Nutrition INC. | $16.18 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaronpaul Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.